H.R. 5343: Ensuring Patient Access to Critical Breakthrough Products Act

H.R. 5343 is a federal bill in the 119th Congress. Currently, medical devices approved through the federal Food and Drug Administration fast-track process must go through a separate, often lengthy review by Medicare before the public health program will pay for them. Under this bill, these designated… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.